CNS Drugs

Abuse-Deterrent and Tamper-Resistant Opioid Formulations: What is their Role in Addressing Prescription Opioid Abuse?
pp. 805-810(6)
Authors: Schneider, Jennifer P.; Matthews, Michele; Jamison, Robert N.

Sleep Problems in the Child with Attention-Deficit Hyperactivity Disorder: Defining Aetiology and Appropriate Treatments
pp. 811-828(18)
Authors: Weiss, Margaret D.; Salpekar, Jay

Role of Pramipexole in the Management of Parkinson's Disease
pp. 829-841(13)
Authors: Antonini, Angelo; Barone, Paolo; Ceravolo, Roberto; Fabbrini, Giovanni; Tinazzi, Michele; Abbruzzese, Giovanni

The Impact of Medications on Quality of Life in Attention-Deficit Hyperactivity Disorder: A Systematic Review
pp. 843-866(24)
Author: Coghill, David

Flupirtine in Pain Management: Pharmacological Properties and Clinical Use
pp. 867-881(15)
Author: Devulder, Jacques

Dalfampridine Extended Release: In Multiple Sclerosis
pp. 883-891(9)
Authors: Chwieduk, Claudine M.; Keating, Gillian M.